Man Group
ONC

Man Group’s BeOne Medicines Ltd ONC Stock Holding History

Man Group’s Portfolio ONC Stock Details ONC Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$87.6M Buy
307,463
+65,541
+27% +$19.3M 0.14% 173
2026
Q1 		$71.8M Sell
241,922
-6,592
-3% -$2.13M 0.13% 172
2025
Q4 		$75.5M Buy
248,514
+39,498
+19% +$12.9M 0.13% 173
2025
Q3 		$71.2M Sell
209,016
-34,845
-14% -$10.6M 0.12% 184
2025
Q2 		$59M Buy
243,861
+90,038
+59% +$22.1M 0.11% 204
2025
Q1 		$41.9M Buy
153,823
+144,231
+1,504% +$33.7M 0.11% 226
2024
Q4 		$1.77M Sell
9,592
-66,635
-87% -$13.6M ﹤0.01% 1347
2024
Q3 		$17.1M Buy
76,227
+67,050
+731% +$12.1M 0.04% 506
2024
Q2 		$1.31M Buy
9,177
+2,342
+34% +$361K ﹤0.01% 1468
2024
Q1 		$1.07M Sell
6,835
-34,308
-83% -$5.52M ﹤0.01% 1522
2023
Q4 		$7.42M Buy
+41,143
New +$7.44M 0.02% 790

Other funds holding ONC

BBA
Baker Bros. Advisors New York $20B AUM 154.41% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $169B AUM 114.72% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $484B AUM 34.9% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $875B AUM 40.91% 1-Year Est. Return
Temasek Holdings
Temasek Holdings Singapore $37.3B AUM 12.6% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Millennium Management
Millennium Management New York $276B AUM 44.8% 1-Year Est. Return

Man Group's ONC Position: Q2 2026 in Review

Man Group increased its BeOne Medicines Ltd (ONC) stake by 27% in Q2 2026, buying an estimated $19.3M and bringing the position to 307,463 shares worth $87.6M. The position accounts for 0.14% of the portfolio, ranked #173.

Man Group first reported a position in ONC in Q4 2023 and has held it in 11 quarters since. 282 funds tracked by Wall St. Rank hold ONC as of Q2 2026.

  • Man Group held 307,463 shares of BeOne Medicines Ltd worth $87.6M as of Q2 2026.
  • Man Group bought 65,541 BeOne Medicines Ltd shares in Q2 2026, an estimated $19.3M.
  • BeOne Medicines Ltd made up 0.14% of Man Group's portfolio in Q2 2026, its #173 holding.
  • Man Group first reported a position in BeOne Medicines Ltd in Q4 2023 and has held it in 11 quarters since.
  • 282 funds tracked by Wall St. Rank held BeOne Medicines Ltd as of Q2 2026.

Based on Man Group's 13F filing for Q2 2026, filed 14 Aug 2026.